The Cytotoxic Effect of Red Beetroot Aqueous Extract on Esophageal Cancer Cell Line KYSE30

Esophageal cancer is one of the most prevalent cancers worldwide, and due to the placement of Iran in the Asian belt of esophageal cancer, the use of modern therapeutic approaches is necessary. Betanin is a natural compound extracted from the red beetroot of Beta vulgaris species whose antioxidant properties and role in removing free radicals have been proven. The present study was conducted to determine the cytotoxic effect of red beetroot aqueous extract on esophageal cancer cell line KYSE30.

In this descriptive-analytical study, esophageal cancer cell line KYSE30 was cultured and then underwent treatment with different concentrations of red beetroot aqueous extract (3, 30, 300, 1000, and 3000 µg/mL) in the three time intervals of 24, 48, and 72 hours. The anticancer effect of treated cells was evaluated by the tetrazolium (MTT) colorimetric assay and the effect of viability was evaluated by the trypan blue assay.

The viability of esophageal cancer cell line at concentrations of 30, 300, 1000, and 3000 μg/mL of red beetroot aqueous extract within 24 hours was statistically significantly reduced compared to the control cells (P<0.05). The viability of esophageal cancer cell line in concentrations of 1000 and 3000 μg/mL of red beetroot aqueous extract within 48 hours showed a statistically significant reduction compared to the control cells (P<0.05). The viability of esophageal cancer cell line at concentrations of 3, 30, 300, 1000, and 3000 μg/mL of red beetroot aqueous extract within 72 hours showed a statistically significant reduction compared to the control cells (P<0.05). The MTT assay results approved the trypan blue assay results. Also, the trypan blue assay indicated that the concentration of 3000 μg/mL significantly led to reduced viability of cells within 72 hours (64.14±3.29) compared to 24 hours (77.22±3.34) and 48 hours (66.93±5.57) (P<0.05).

Red beetroot aqueous extract has a cytotoxic effect on esophageal cancer cell line KYSE30.